Journal Club: Optimizing the Injection Schema for 200 or 300 Units of OnabotulinumtoxinA (BTX-A) in the Office Setting

In this episode, join Dr. Rose Khavari and Dr.Argy Stampas with host, Elizabeth-Sarah Bile,  as we discuss their newest research findings on “Optimizing the Injection Schema for 200 or 300 Units of OnabotulinumtoxinA (BTX-A) in the Office Setting”. Tune in to discover the findings of this randomized trial and how it benefits patients with Neurogenic Lower Urinary Tract Dysfunction (NLUTD) and Idiopathic Overactive Bladder.https://www.nbrg.org/ [nbrg.org]https://www.khavariresearch.com/ [khavariresearch.com]https://www.youtube.com/watch?v=Eu93ufLvSLs [youtube.com]